Akeso Cadonilimab Combo Shows Strong Survival in Pancreatic Cancer
Hong Kong, April 20, 2026 In a significant breakthrough in oncology immunotherapy, Akeso, Inc. has announced promising Phase II...
Pancreatic Cancer
Advertisement
AIM ImmunoTech Advances Ampligen Phase 3 Cancer Trial
OCALA, Fla., April 16, 2026 AIM ImmunoTech Inc. has announced significant progress in its oncology pipeline, entering a pivotal...
AnBogen Therapeutics Showcases ABT-301 Cancer Breakthroughs
TAIPEI, Taiwan, April 13, 2026 AnBogen Therapeutics has announced that its lead investigational therapy Imofinostat (ABT-301) will be featured...
Revolution Medicines Advances Daraxonrasib Into Phase 3
REDWOOD CITY, Calif., April 2, 2026 Revolution Medicines has announced the initiation of patient dosing in its global Phase...
Novocure PANOVA-4 Trial Shows Positive Cancer Results
Baar, Switzerland – March 2026 Novocure announced positive topline results from its Phase 2 PANOVA-4 clinical trial evaluating Tumor...
Advertisements
FAPI-74 Phase 3 Trial Doses First Pancreatic Patient
DULLES, Va., Feb. 11, 2026 — SOFIE Biosciences announced that the first patient has been dosed in its Phase...
Autonomix Reports Rapid, Durable Pain Relief in Pancreatic Cancer
THE WOODLANDS, Texas | January 9, 2026 — Autonomix Medical, Inc. has reported compelling proof-of-concept (PoC) clinical data demonstrating...
Alligator to Present New Mitazalimab Data at ASCO GI 2026
LUND, Sweden | January 9, 2026 — Alligator Bioscience announced that new clinical data from its Phase 1b/2 OPTIMIZE-1...
Morphocell Secures $50M to Advance Stem-Cell Liver Therapy
Laval, Québec, December 1, 2025 — Morphocell Technologies has announced the successful completion of its US$50 million Series A...
Can-Fite Highlights Major Progress Across Late-Stage Drug Pipeline
Ramat Gan, Israel, November 26, 2025 — Can-Fite BioPharma has announced key updates across its advanced-stage clinical pipeline ahead...
Advertisement
